Description
IGF-1 LR3 1MG
1mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
IGF-1 LR3 1mg (Insulin-like Growth Factor-1 Long Arg3) is a synthetic, high-potency analog of human IGF-1, specifically modified with an 83-amino acid sequence that includes an arginine substitution at position 3. In structural biology and cellular laboratory research, this modification significantly alters its properties by dramatically reducing its affinity for IGF-binding proteins (IGFBPs). As a result, experimental models focus on its extended half-life, its role in receptor-mediated signaling pathways, and its influence on cellular proliferation, hypertrophic response mechanisms, and protein synthesis assays. Explore our full range of Research Peptides.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | IGF-1 LR3 1mg |
| Sequence | MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA |
| Molecular Formula | C400H625N111O115S9 |
| Molecular Weight | 9117.6 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 1 mg per vial |
| Grade | Laboratory Research Grade |
Research Application Areas
- IGFBP-Binding Avoidance: Evaluation of signaling efficiency when traditional binding protein constraints are bypassed.
- Cellular Proliferation & Myogenesis: Research into pathways stimulating satellite cell activation and lean tissue cell development models.
- Extended Half-Life Studies: Comparative structural testing mapping the prolonged pharmacokinetic lifespan versus native IGF-1.
- Protein Synthesis Optimization: Analysis of intracellular signaling cascades responsible for amino acid uptake and protein construction.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
